1001-2494
2015 Issue 6
Comments and Suggestions on Development and Evaluation of Biosimilars
LUO Jian-hui;WEI Wei;XIANG Jin-zhong;WANG Hai-xue;XIE Song-mei;YIN Hong-zhang;BAI Yu;Center for Drug Evaluation;China Food and Drug Administration;
LUO Jian-hui;WEI Wei;XIANG Jin-zhong;WANG Hai-xue;XIE Song-mei;YIN Hong-zhang;BAI Yu;Center for Drug Evaluation;China Food and Drug Administration;
..............page:473-476
..............page:473
Challenges of Pharmaceutical Evaluation of Biosimilars
BAI Yu;WANG Hai-xue;XIE Song-mei;GAO Chen-yan;WANG Qing-li;YIN Hong-zhang;LUO Jian-hui;Center for Drug Evaluation;China Food and Drug Administration;
BAI Yu;WANG Hai-xue;XIE Song-mei;GAO Chen-yan;WANG Qing-li;YIN Hong-zhang;LUO Jian-hui;Center for Drug Evaluation;China Food and Drug Administration;
..............page:477-479
Technical Considerations on Non-Clinical Study and Evaluation for Biosimilar Products
WANG Hai-xue;BAI Yu;XIE Song-mei;GAO Chen-yan;LUO Jian-hui;YIN Hong-zhang;WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;
WANG Hai-xue;BAI Yu;XIE Song-mei;GAO Chen-yan;LUO Jian-hui;YIN Hong-zhang;WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;
..............page:480-482
Technical Considerations on the Study and Evaluation of the Biosimilars’ Immunogenicity
WANG Hai-xue;LU Guo-cai;ZHANG Zi-teng;YUAN Bo-jun;WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;Center for Evaluation of Drug Safety;Second Military Medical University;
WANG Hai-xue;LU Guo-cai;ZHANG Zi-teng;YUAN Bo-jun;WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;Center for Evaluation of Drug Safety;Second Military Medical University;
..............page:483-489
Considerations for Design and Evaluation of Clinical Similarity Comparison Trial of Biosimilars
XIE Song-mei;GAO Chen-yan;BAI Yu;WANG Hai-xue;YANG Zhi-min;LUO Jian-hui;WANG Qing-li;ZHAO Jian-zhong;ZHUO Hong;YIN Hong-zhang;WANG Tao;Center for Drug Evaluation;China Food and Drug Administration;
XIE Song-mei;GAO Chen-yan;BAI Yu;WANG Hai-xue;YANG Zhi-min;LUO Jian-hui;WANG Qing-li;ZHAO Jian-zhong;ZHUO Hong;YIN Hong-zhang;WANG Tao;Center for Drug Evaluation;China Food and Drug Administration;
..............page:490-493
Considerations on Clinical Study of Biosimilars
GAO Chen-yan;XIE Song-mei;BAI Yu;WANG Hai-xue;WANG Tao;WANG Qing-li;LUO Jian-hui;YIN Hong-hang;YANG Zhi-min;Center for Drug Evaluation;China Food and Drug Administration;
GAO Chen-yan;XIE Song-mei;BAI Yu;WANG Hai-xue;WANG Tao;WANG Qing-li;LUO Jian-hui;YIN Hong-hang;YANG Zhi-min;Center for Drug Evaluation;China Food and Drug Administration;
..............page:494-496
Study on the Flavonoid Glycosides from the Herb of Clematis connata DC
YUAN Lin;HUANG Wen-zhong;LIANG De-qiang;MA Yin-hai;DU Zhi-zhi;Chemical Science and Technology Department;Kunming University;State Key Laboratory of Phytochemistry and Plant Resources in West China;Kunming Institute of Botany;Chinese Academy of Sciences;
YUAN Lin;HUANG Wen-zhong;LIANG De-qiang;MA Yin-hai;DU Zhi-zhi;Chemical Science and Technology Department;Kunming University;State Key Laboratory of Phytochemistry and Plant Resources in West China;Kunming Institute of Botany;Chinese Academy of Sciences;
..............page:497-501
zhong guo yao xue za zhi 2015 nian zheng ding qi shi
ben kan xun ;
ben kan xun ;
..............page:501
Chemical Constituents from Swertia cincta Burk. and Their Antagonistic Effects on Benign Prostatic Hyperplasia
LI Shang-xiu;WANG Ting;TIAN Qian;ZHANG Hai-fen;LI Gan-peng;GUO Gang;Laboratory of Ethnic Medicine Resource Chemistry;State Ethnic Affairs Commission & Ministry of Education;School of Chemistry and Biotechnology;Yunnan University of Nationalities;Department of Thoracic Surgery;Third Affiliated Hospital of Kunming Medical University;
LI Shang-xiu;WANG Ting;TIAN Qian;ZHANG Hai-fen;LI Gan-peng;GUO Gang;Laboratory of Ethnic Medicine Resource Chemistry;State Ethnic Affairs Commission & Ministry of Education;School of Chemistry and Biotechnology;Yunnan University of Nationalities;Department of Thoracic Surgery;Third Affiliated Hospital of Kunming Medical University;
..............page:502-506
Mechanism of Vaccinium vitis Procyanidin Induced the Apoptosis of SHG-44 Glioma Cells through Mitochodrial Pathway
ZHONG Yue;QI Ling;REN Kuang;WANG Wei-yao;SHEN Nan;JIN Hong;TIAN Jing;ZHAO Dong-hai;Department of Scientific Research;Jilin Medical College;College of Basic Medicine;Jilin Medical College;
ZHONG Yue;QI Ling;REN Kuang;WANG Wei-yao;SHEN Nan;JIN Hong;TIAN Jing;ZHAO Dong-hai;Department of Scientific Research;Jilin Medical College;College of Basic Medicine;Jilin Medical College;
..............page:507-511
guan yu tui jian 2015 nian du zhong guo yao xue fa zhan jiang chuang xin yao wu jiang hou xuan ren de tong zhi
ben kan xun ;
ben kan xun ;
..............page:511
Drug Distribution During in Vitro Lipolysis of SNEDDSs Containing Griseofulvin
LIN Wan-ting;LONG Xiao-ying;WU Hui-yi;LU Bin;ZHANG Ying-feng;Guangdong Pharmaceutical University;
LIN Wan-ting;LONG Xiao-ying;WU Hui-yi;LU Bin;ZHANG Ying-feng;Guangdong Pharmaceutical University;
..............page:512-520
Synthesis and Characterization of Novel Vesicles of Self-Assembly Cyclodextrin and the Including Properties of Water-Soluble Drugs
GUO Ming;FEI Meng;MA Yan-fei;WANG Xiang-jun;School of Science;Zhejiang Agricultural & Forestry University;Department of Chinese Materia Medica;Zhejiang Agricultural & Forestry University;
GUO Ming;FEI Meng;MA Yan-fei;WANG Xiang-jun;School of Science;Zhejiang Agricultural & Forestry University;Department of Chinese Materia Medica;Zhejiang Agricultural & Forestry University;
..............page:521-526
The Pharmacokinetic-Pharmacodynamic Study of Novel Antidiabetic Drug Saxagliptin in Chinese Schizophrenia Patients Complicated with T2DM
HU Jin-qing;ZHANG Ming;LIANG Jiong-he;SHANG De-wei;NI Xiao-jia;QIU Chang;WANG Zhan-zhang;WU Fu-xi;ZENG Yi-bin;WEN Yu-guan;Institution of National Drug Clinical Trials;Guangzhou Huiai Hospital;Department of Chronic Psychiatry;Guangzhou Huiai Hospital;
HU Jin-qing;ZHANG Ming;LIANG Jiong-he;SHANG De-wei;NI Xiao-jia;QIU Chang;WANG Zhan-zhang;WU Fu-xi;ZENG Yi-bin;WEN Yu-guan;Institution of National Drug Clinical Trials;Guangzhou Huiai Hospital;Department of Chronic Psychiatry;Guangzhou Huiai Hospital;
..............page:527-531
Moisture Sorption Properties Research of Chemical Reference Substances Based on Dynamic Vapor Sorption Analysis Technology
XIONG Jing;YANG Hua-xin;WU Jian-min;HE Lan;National Institutes for Food and Drug Control;
XIONG Jing;YANG Hua-xin;WU Jian-min;HE Lan;National Institutes for Food and Drug Control;
..............page:532-535
Determination of Contents and Related Substances of Felodipine and Metoprolol Tartrate in Compound Felodipine Sustained-Release Tablets by HPLC
YANG Guang;LI Zhi-ping;LIU Yan;LI Ying;SONG Yan-ling;MEI Xing-guo;Pharmaceutical and Biological Engineering College;Shenyang University of Chemical Technology;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
YANG Guang;LI Zhi-ping;LIU Yan;LI Ying;SONG Yan-ling;MEI Xing-guo;Pharmaceutical and Biological Engineering College;Shenyang University of Chemical Technology;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;
..............page:536-540
RP-HPLC Assay Method for Related Substances of Ambrisentan Tablets
WANG Bo;LI Hong-qi;LIAN Xiao-yan;MENG Ce;REN Xiao-wen;The Pharmaceutics Engineering Research Center;Tianjin Institute of Pharmaceutical Research;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research;
WANG Bo;LI Hong-qi;LIAN Xiao-yan;MENG Ce;REN Xiao-wen;The Pharmaceutics Engineering Research Center;Tianjin Institute of Pharmaceutical Research;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research;
..............page:541-544
Synthesis and Antitumor Activity of Fluoroquinolon-3-yl s-triazole Sulfanylacetylhydrazones and s-Triazole Hydrazone Derivatives( Ⅴ)
GAO Liu-zhou;LI Tao;XIE Yu-suo;HU Guo-qiang;HUANG Wen-long;Institute of Chemical Biology;Henan University;Centre of Drug Discovery;China Pharmaceutical University;
GAO Liu-zhou;LI Tao;XIE Yu-suo;HU Guo-qiang;HUANG Wen-long;Institute of Chemical Biology;Henan University;Centre of Drug Discovery;China Pharmaceutical University;
..............page:545-549
Rifampin and Increase of Warfarin Dose: A Case Report and Review of the Literature
MENG Hui-jie;SHI Wei-long;HU Yong-fang;Department of Pharmacy;Peking University Third Hospital;Department of Administration and Clinical Pharmacy;Peking University School of Pharmaceutical Sciences;Beijing Tsinghua Changgung Hospital;
MENG Hui-jie;SHI Wei-long;HU Yong-fang;Department of Pharmacy;Peking University Third Hospital;Department of Administration and Clinical Pharmacy;Peking University School of Pharmaceutical Sciences;Beijing Tsinghua Changgung Hospital;
..............page:550-553
Impact of Pharmacist-Participated Anticoagulation Service on Warfarin Therapy Management: A Systematic Review
LUO Min;WU Bin;WU Feng-bo;SU Na;XU Ting;Department of Pharmacy;West China Hospital of Sichuan University;
LUO Min;WU Bin;WU Feng-bo;SU Na;XU Ting;Department of Pharmacy;West China Hospital of Sichuan University;
..............page:554-558
Prevalence and Risk Factors for Poor Medication Adherence Among Chinese Hypertensive Patients
ZHAO Yue;QI Wei-lin;YANG Ai-fang;WANG Bin;ZHONG Ming-kang;Department of Pharmacy;Huashan Hospital;Fudan University;Department of Cardiology;Huashan Hospital;Fudan University;
ZHAO Yue;QI Wei-lin;YANG Ai-fang;WANG Bin;ZHONG Ming-kang;Department of Pharmacy;Huashan Hospital;Fudan University;Department of Cardiology;Huashan Hospital;Fudan University;
..............page:559-562
..............page:563
..............page:564